CA
HUMA icon

Cetera Advisors’s Humacyte HUMA Stock Holding History

Cetera Advisors’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$31.4K Buy
+10,105
New +$34K ﹤0.01% 2375

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Cetera Advisors's HUMA Position: Q1 2024 in Review

Cetera Advisors opened a new position in Humacyte (HUMA) in Q1 2024: 10,105 shares worth $31.4K. The stake represents ﹤0.01% of the portfolio and ranks #2375 among its holdings.

96 funds tracked by Wall St. Rank hold HUMA as of Q1 2024.

  • Cetera Advisors held 10,105 shares of Humacyte worth $31.4K as of Q1 2024.
  • Humacyte was a new Cetera Advisors position in Q1 2024.
  • Humacyte made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2375 holding.
  • 96 funds tracked by Wall St. Rank held Humacyte as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.